Cat allergen-induced blood basophil reactivity in vitro predicts acute human nasal allergen challenge responses in vivo

Clinical and Experimental Allergy

Volumn 41, Issue 7, 2011, Pages 963-969

  Paterniti, M ^a   Kelly, D C ^a   Eckman, J A ^a   Sterba, P M ^a   Hamilton, R G ^a   Bochner, B S ^a   Macglashan, D W ^a   Saini, S S ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Basophils; Cat allergen; Nasal allergen challenge; Specific ige; Specific ige total ige ratio

Indexed keywords

ALLERGEN; CAT ALLERGEN; HISTAMINE; IMMUNOGLOBULIN E; OMALIZUMAB; UNCLASSIFIED DRUG;

ADULT; ALLERGY; ALLERGY TEST; ARTICLE; BASOPHIL; BASOPHIL HISTAMINE RELEASE; CAT; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOMESTIC ANIMAL ALLERGY; FEMALE; HISTAMINE RELEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; NASAL ALLERGEN CHALLENGE; PERENNIAL RHINITIS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PUNCTURE SKIN TEST; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; SKIN TEST; SNEEZING;

ADULT; ALLERGENS; ANIMALS; ANTIBODY SPECIFICITY; BASOPHILS; CATS; FEMALE; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; NASAL PROVOCATION TESTS; PREDICTIVE VALUE OF TESTS; RESPIRATORY HYPERSENSITIVITY; SKIN TESTS; YOUNG ADULT;

EID: 79958777010     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03719.x     Document Type: Article

References (22)

1. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol 2007; 19:23-34.
2. Naclerio RM, Proud D, Togias AG et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313:65-70.
3. Eckman JA, Sterba PM, Kelly D et al. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. J Allergy Clin Immunol 2010; 125:889-95.e7.
4. Norman PS, Lichtenstein LM, Ishizaka K. Diagnostic tests in ragweed hay fever. A comparison of direct skin tests, IgE antibody measurements, and basophil histamine release. J Allergy Clin Immunol 1973; 52:210-24.
5. Sainte-Laudy J, Sabbah A, Drouet M, Lauret MG, Loiry M. Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin tests, specific IgE, histamine and leukotriene C4 release. Clin Exp Allergy 2000; 30:1166-71.
6. Paltiel M, Gober LM, Deng A et al. Immediate type I hypersensitivity response implicated in worsening injection site reactions to adalimumab. Arch Dermatol 2008; 144:1190-94.
7. de Weck AL, Sanz ML, Gamboa PM et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Arch Allergy Immunol 2008; 146:177-89.
8. Wanich N, Nowak-Wegrzyn A, Sampson HA, Shreffler WG. Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol 2009; 123:789-94.e20.
9. Busse WW, Swenson CA, Sharpe G, Koschat M. Enhanced basophil histamine release to concanavalin A in allergic rhinitis. J Allergy Clin Immunol 1986; 78 (1 Pt 1):90-7.
10. Casolaro V, Spadaro G, Marone G. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis 1990; 142:1108-11.
11. Gaddy JN, Busse WW. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma. Am Rev Respir Dis 1986; 134:969-74.
12. Youssef LA, Schuyler M, Gilmartin L et al. Histamine release from the basophils of control and asthmatic subjects and a comparison of gene expression between 'releaser' and 'nonreleaser' basophils. J Immunol 2007; 178:4584-94.
13. Vonakis BM, Vasagar K, Gibbons SP Jr et al. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol 2007; 119:441-8.
14. Saini SS, Richardson JJ, Wofsy C, Lavens-Phillips S, Bochner BS, Macglashan DW Jr. Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils. J Allergy Clin Immunol 2001; 107:832-41.
15. Linder A. Symptom scores as measures of the severity of rhinitis. Clin Allergy 1988; 18:29-37.
16. Naclerio RM, Meier HL, Kagey-Sobotka A et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983; 128:597-602.
17. Hamilton RG, MacGlashan DW Jr, Saini SS. IgE antibody-specific activity in human allergic disease. Immunol Res 2010; 47:273-84.
18. Chai H, Farr RS, Froehlich LA et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56:323-7.
19. Christensen LH, Holm J, Lund G, Riise E, Lund K. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. J Allergy Clin Immunol 2008; 122:298-304.
20. Knol EF, Verhoeven AJ, Roos D. Stimulus secretion coupling in human basophilic granulocytes. Clin Exp Allergy 1993; 23:471-80.
21. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM. Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 1999; 104 (2 Pt 1):279-84.
22. Mamiya S, Ito H, Suzuki M, Takagi I, Baba S, Nishimura J. Clinical evaluation of histamine release test: a novel method for identifying allergens from the whole blood of allergic patients. Acta Otolaryngol Suppl 1996; 525:93-7.